We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has AdaptHealth Corp. (AHCO - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
AdaptHealth Corp. is one of 1051 individual stocks in the Medical sector. Collectively, these companies sit at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. AdaptHealth Corp. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AHCO's full-year earnings has moved 15.6% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that AHCO has returned about 34.6% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 1.7% on average. This shows that AdaptHealth Corp. is outperforming its peers so far this year.
Another Medical stock, which has outperformed the sector so far this year, is Arcutis Biotherapeutics, Inc. (ARQT - Free Report) . The stock has returned 170.6% year-to-date.
Over the past three months, Arcutis Biotherapeutics, Inc.'s consensus EPS estimate for the current year has increased 6%. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, AdaptHealth Corp. belongs to the Medical - Products industry, a group that includes 91 individual companies and currently sits at #152 in the Zacks Industry Rank. This group has gained an average of 1.8% so far this year, so AHCO is performing better in this area.
On the other hand, Arcutis Biotherapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 506-stock industry is currently ranked #78. The industry has moved -7.6% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to AdaptHealth Corp. and Arcutis Biotherapeutics, Inc. as they could maintain their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has AdaptHealth Corp. (AHCO - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
AdaptHealth Corp. is one of 1051 individual stocks in the Medical sector. Collectively, these companies sit at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. AdaptHealth Corp. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AHCO's full-year earnings has moved 15.6% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that AHCO has returned about 34.6% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 1.7% on average. This shows that AdaptHealth Corp. is outperforming its peers so far this year.
Another Medical stock, which has outperformed the sector so far this year, is Arcutis Biotherapeutics, Inc. (ARQT - Free Report) . The stock has returned 170.6% year-to-date.
Over the past three months, Arcutis Biotherapeutics, Inc.'s consensus EPS estimate for the current year has increased 6%. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, AdaptHealth Corp. belongs to the Medical - Products industry, a group that includes 91 individual companies and currently sits at #152 in the Zacks Industry Rank. This group has gained an average of 1.8% so far this year, so AHCO is performing better in this area.
On the other hand, Arcutis Biotherapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry. This 506-stock industry is currently ranked #78. The industry has moved -7.6% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to AdaptHealth Corp. and Arcutis Biotherapeutics, Inc. as they could maintain their solid performance.